Drug Pipeline

SHR-1701 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
0
Recruiting
5
Top Sponsors
Active Studies by Phase
Phase 2
5
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07355010 A Randomized, Open-label, Double-cohort Study of Fluzoparib Combined With Famitinib… Ovarian Cancer Not Yet Recruiting
NCT07384234 SHR-1701 Combined With Chemotherapy for Gastric or Gastroesophageal Junction… Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma Not Yet Recruiting
NCT07464756 SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy… Gastric Adenocarcinoma Not Yet Recruiting
NCT07503639 Umbrella Trial of Neoadjuvant Therapy for Locally Advanced Colorectal Cancer Locally Advanced Colorectal Cancer Not Yet Recruiting
NCT07517653 Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable… Melanoma Not Yet Recruiting
Sponsors Running SHR-1701 Trials
Disease Areas
Get alerts when SHR-1701 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free